Surrozen (SRZN) Return on Equity [ROE] (2021 - 2025)
Surrozen (SRZN) recorded Return on Equity [ROE] of -300.23% in Q3 2025, up 123.61 percentage points from -423.84% a year earlier but down 210.10 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2024, Surrozen reported Return on Equity [ROE] of -288.08%, down 211.83 percentage points from FY2023.
- Annual Return on Equity [ROE] has a three-year change of -218.88 percentage points (FY2021 to FY2024).
- Across earlier years, Return on Equity [ROE] came in at -76.25% in FY2023 (-29.34 pp), -46.91% in FY2022 (+22.29 pp) and -69.20% in FY2021.
- Quarterly Return on Equity [ROE] has ranged from -423.84% in Q3 2024 to -46.54% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last six quarters, with an average year-over-year change of -58.42 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 123.61 percentage points in Q3 2025, against a drop of 352.42 percentage points in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Surrozen | 344.63 Mn | 344.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -300.23% |
| Jun 30, 2025 | -90.13% |
| Sep 30, 2024 | -423.84% |
| Jun 30, 2024 | -204.69% |
| Mar 31, 2024 | -112.06% |
| Dec 31, 2023 | -104.09% |
| Sep 30, 2023 | -71.42% |
| Jun 30, 2023 | -65.71% |
| Mar 31, 2023 | -62.08% |
| Dec 31, 2022 | -56.76% |
| Sep 30, 2022 | -67.97% |
| Jun 30, 2022 | -59.37% |
| Mar 31, 2022 | -52.50% |
| Dec 31, 2021 | -46.54% |
| Sep 30, 2021 | -54.31% |
| Jun 30, 2021 | -120.50% |
API Access
Surrozen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();